查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1376012

精準醫療市場規模、佔有率和趨勢分析報告：2023-2030 年按應用、最終用途、地區和細分市場分類的趨勢

Precision Medicine Market Size, Share & Trends Analysis Report By Application (Diagnostics (Genetic Tests, Esoteric Tests)), Therapeutics (Pharmaceuticals, Medical Devices), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

精準醫療市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球精準醫療市場規模將達到1,607.8億美元，2023年至2030年年複合成長率為10.7%。

引入具有成本效益的基因組和分子生物學檢測方法、癌症和罕見疾病盛行率的增加以及精準醫療中巨量資料的使用增加等趨勢是推動市場成長的關鍵因素。

人類基因計劃引入了令人興奮的最尖端科技，例如全基因組序列測定和靶向序列測定。研究人員利用這些技術來研究基因組並創造治療各種疾病的個體化療法。如今，世界各地腫瘤學、免疫學和神經學等領域的疾病盛行率正在迅速增加。

研究人員、醫療保健專業人員以及大型製藥和生物技術公司正在共同努力，為患者健康發現新的治療方法選擇。許多治療方法和藥物目前正在進行臨床試驗以治療各種類型的癌症。此外，研究人員有興趣在癌症以外的疾病領域開發精準醫學和診斷方法。

除了治療之外，診斷領域近年來也經歷了快速成長。次世代定序（NGS）、生物標記、伴隨診斷和深奧測試的使用有可能改變和影響藥物處方模式。個體化藥物很可能在未來20年內取得巨大成功，並有能力治療和治癒少數以前不可能的疾病。

政府和法規機構的參與對該行業的發展發揮著至關重要的作用。 2015年，時美國政府宣布推出精準醫療計畫。隔年，中國啟動了中國精準醫療計畫。這是一項為期15年的計劃，旨在將國家打造成精準治療發展的領導者。

目前，生物技術和製藥公司改進產品線中超過 40% 的藥物都含有生物標記。該簡報還建議，一些生物製藥公司在過去年度中已經建立了合作和合資企業，預計在未來年度將繼續下去。因此，診斷和治療精準醫學市場潛力巨大，並正在迅速轉變為患者照護的基本領域。

精準醫療市場報告亮點

  • 基因序列測定、生物標記、巨量資料分析和伴隨診斷等技術預計將在未來年度推動這一市場。
  • 從最終用途來看，臨床實驗室將在 2022 年佔據主導市場。同時，居家醫療檢測領域因其速度、效率和便利性而正在快速發展。
  • 依適應症領域分類，2022年癌症治療精準藥物佔最大市場佔有率。然而，研究人員正在將重點轉向開發針對非腫瘤疾病的精準藥物。因此，免疫、遺傳和罕見疾病越來越受到關注。
  • 北美市場目前佔據最大佔有率，預計在預測期內將進一步成長。市場主要受到政府支持性政策和措施以及市場參與者的強大推動。亞太地區預計將成為該市場成長最快的地區。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 精準醫療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 精準醫療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 精準醫療：應用預估與趨勢分析

  • 精準醫療市場：要點
  • 精準醫療市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 診斷
    • 2018年至2030年診斷市場估計與預測
    • 基因檢測
    • 直接面對消費者的測試
    • 困難的考驗
    • 其他
  • 治療
    • 2018年至2030年治療藥物市場估計與預測
    • 藥品
    • 醫療設備
    • 其他

第5章 精準醫療：最終用途估計與趨勢分析

  • 精準醫療市場：要點
  • 精準醫療市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 居家護理
  • 醫院
  • 臨床實驗室
  • 其他

第6章 精準醫療市場：區域估算與趨勢分析

  • 區域展望
  • 按地區分類的精準醫療市場：主要市場亮點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • F. Hoffmann-La Roche Ltd.-Foundation Medicine
    • Siemens Healthineers
    • Janssen Pharmaceuticals
    • Illumina
    • Quest Diagnostics Incorporated.
    • 23andMe, Inc.
    • NeoDiagnostix, Inc.,
    • IBM Watson
    • Myriad Genetics Inc.
    • Medtronic
    • GE Healthcare
    • Abbott Laboratories
    • Dako A/S
    • Biogen
    • Precision Biologics Incorporated
    • Qiagen Incorporated
Product Code: GVR-2-68038-612-7

Precision Medicine Market Growth & Trends:

The global precision medicine market size is expected to reach USD 160.78 billion by 2030 growing at a CAGR of 10.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies.

At present, more than 40% of the medications in biotech and pharmaceutical companies' improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care.

Precision Medicine Market Report Highlights:

  • Technologies such as gene sequencing, biomarkers, big data analytics, and companion diagnostics are anticipated to drive this market in the coming years
  • By end use, clinical labs held the dominant share in the market in 2022. The home care testing segment, on the other hand, has been witnessing rapid growth due to its speed, efficiency, and convenience
  • On the basis of indication area, therapeutic precision medicines for oncology held the largest market share in 2022. However, there has been a change in focus of researchers toward the development of precision medicines for non-oncologic diseases. This has resulted in greater focus on immunological, genetic, and rare diseases
  • The North America market currently holds the largest share and is expected to grow further during the forecast period. The market is primarily driven by supportive policies and initiatives by the government and strong presence of market players. Asia Pacific is expected to emerge as the fastest growing region in this market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Precision Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Precision Medicine Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Precision Medicine: Application Estimates & Trend Analysis

  • 4.1. Precision Medicine Market: Key Takeaways
  • 4.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Diagnostics
    • 4.3.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Genetic tests
      • 4.3.2.1. Genetic tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Direct to consumer tests
      • 4.3.3.1. Direct to consumer tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Esoteric tests
      • 4.3.4.1. Esoteric tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Therapeutics
    • 4.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Pharmaceuticals
      • 4.4.2.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Oncology
      • 4.4.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Respiratory diseases
      • 4.4.2.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.4. Skin diseases
      • 4.4.2.4.1. Skin diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.5. CNS disorders
      • 4.4.2.5.1. CNS disorders market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.6. Immunology
      • 4.4.2.6.1. Immunology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.7. Genetic diseases
      • 4.4.2.7.1. Genetic diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.8. Others
      • 4.4.2.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Medical Devices
      • 4.4.3.1. Medical Devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Precision Medicine: End Use Estimates & Trend Analysis

  • 5.1. Precision Medicine Market: Key Takeaways
  • 5.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Home Care
    • 5.3.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Clinical Laboratories
    • 5.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Precision Medicine Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F. Hoffmann-La Roche Ltd.-Foundation Medicine
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Siemens Healthineers
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Janssen Pharmaceuticals
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Illumina
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Quest Diagnostics Incorporated.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. 23andMe, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. NeoDiagnostix, Inc.,
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. IBM Watson
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Myriad Genetics Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Medtronic
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. GE Healthcare
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Abbott Laboratories
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Dako A/S
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Biogen
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Precision Biologics Incorporated
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Qiagen Incorporated
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 17 France precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 31 China precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 32 China precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 36 India precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Australia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 38 Australia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 42 South Korea precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 47 Brazil precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait precision medicine market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Precision medicine: Market outlook
  • Fig. 9 Precision medicine: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Precision medicine market driver impact
  • Fig. 15 Precision medicine market restraint impact
  • Fig. 16 Precision medicine market strategic initiatives analysis
  • Fig. 17 Precision medicine market: Application movement analysis
  • Fig. 18 Precision medicine market: Application outlook and key takeaways
  • Fig. 19 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Genetic tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Direct to consumer tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Esoteric tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Skin diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 CNS disorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Genetic diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Medical devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Precision medicine market: End-use movement analysis
  • Fig. 36 Precision medicine market: End-use outlook and key takeaways
  • Fig. 37 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global precision medicine market: Regional movement analysis
  • Fig. 42 Global precision medicine market: Regional outlook and key takeaways
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)